Genital viral infections in clinical practice: effectiveness of complex treatment-Reference-Cited by-同舟云学术

Genital viral infections in clinical practice: effectiveness of complex treatment

Published:2019-10-10 Issue:13 Volume: Page:166-171
ISSN:2658-5790
Container-title:Medical Council
language:
Short-container-title:Medicinskij sovet

Author:

Nazarova N. M.¹^ORCID,Attoeva D. I.¹,Dovletkhanova E. R.¹^ORCID,Prilepskaya V. N.¹^ORCID

Affiliation:

1. National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov

Abstract

Recurrent genital herpes and anogenital warts differ in etiological factor and clinical presentation. The main objectives afflicting the gynecologist are to lengthen the period of remission as long as practicable and reduce recurrence rates of genital warts. The article presents the analysis of the effectiveness and safety of the complex therapy for recurrent genital herpes and anogenital (venereal) warts.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference16 articles.

1. Looker K.J., Magaret A.S., Turner K.M., Vickerman P., Gottlieb S.L., Newman L.M. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One. 201521;10(1):e114989. doi: 10.1371/journal.pone.0114989.

2. Ryder N., Jin F., McNulty A.M., Grulich A.E., Donovan B. Donovan B. Increasing role of herpes simplex virus type 1 in first-episode anogenital herpes in heterosexual women and younger men who have sex with men, 19922006. Sex Transm Infect. 2009 Oct;85(6):416419. doi: 10.1136/sti.2008.033902.

3. Bosch F.X., Broker T.R., Forman D., Moscicki A.B., Gillison M.L., Doorbar J., Stern P.L., Stanley M., Arbyn M., Poljak M., Cuzick J., Castle P.E., Schiller J.T., Markowitz L.E., Fisher W.A., Canfell K., Denny L.A., Franco E.L., Steben M., Kane M.A., Schiffman M., Meijer C.J., Sankaranarayanan R., Castellsague X., Kim J.J., Brotons M., Alemany L., Albero G., Diaz M., de Sanjose S. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013;31(Suppl 7):H1-31. doi: 10.1016/j.vaccine.2013.10.003.

4. Park I.U., Introcaso C., Dunne E.F. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis. 2015;61(Suppl 8):849-855. doi: 10.1093/cid/civ813.

5. Fleider L.A., Tatti S.A., Suzuki A.V., Maldonado V.A., Diaz L.B., Chiesa I.J., Perez M.S. Human Papillomavirus Types Involved in External Genital Warts in a Group of Argentinian Women in Buenos Aires. Journal of Lower Genital Tract Disease. 2016;20(4):365–366. doi: 10.1097/LGT.0000000000000249.